Similarly, a research in endothelin-1 (ET-1) has emphasized the use of ET-1 treatment resulted in heterologous desensitization of insulin signalling, defined as chronic ET-1-induced cellular insulin resistance. The gene discussed is INS; the disease is Insulin resistance.